Literature DB >> 1939265

Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study.

A Sánchez1, W K Jones, J Gulick, T Doetschman, J Robbins.   

Abstract

Embryoid bodies (EBs) are obtained when mouse pluripotential embryonic stem cells are grown in the absence of an embryonic fibroblast feeder layer. Seven- to 9-day-old EBs undergo rhythmical, spontaneous contractions and express the appropriate tissue- and developmental stage-specific cardiac and skeletal myosin heavy chain (MHC) genes. To study the expression patterns of these MHC genes in vitro we isolated and partially sequenced the cDNAs expressed in EBs such that specific oligonucleotides suitable for polymerase chain reaction analyses and appropriate riboprobes for in situ hybridizations could be made. The data show the beta-cardiac gene is expressed first during EB development (days 3 and 4), and alpha-cardiac gene expression begins at approximately day 8. A similar pattern of expression is also detected during mouse embryogenesis in utero. Only those EBs that expressed both the alpha- and beta-cardiac transcripts contracted. In situ hybridization of EBs using riboprobes shows that the spatial distribution of the cardiac MHC transcripts differs. No expression of the genes was detected in day 8 or older nonbeating EBs. These data suggest that developing EBs closely mimic the pre- and early postsomitic patterns of in vivo expression of the cardiac MHC genes and thus provide a useful system in which to study early aspects of mammalian cardiogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939265

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.

Authors:  M G Klug; M H Soonpaa; G Y Koh; L J Field
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

3.  High-resolution genetic mapping of the gunmetal gene which regulates platelet production.

Authors:  E P O'Brien; L Zhen; S Y Jiang; E K Novak; R T Swank
Journal:  Mamm Genome       Date:  1996-03       Impact factor: 2.957

4.  The latent transforming growth factor-beta-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium.

Authors:  A Gualandris; J P Annes; M Arese; I Noguera; V Jurukovski; D B Rifkin
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

5.  Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.

Authors:  W K Jones; I L Grupp; T Doetschman; G Grupp; H Osinska; T E Hewett; G Boivin; J Gulick; W A Ng; J Robbins
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 6.  In vitro differentiation of murine embryonic stem cells. New approaches to old problems.

Authors:  M J Weiss; S H Orkin
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

7.  Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos.

Authors:  M Muthuchamy; L Pajak; P Howles; T Doetschman; D F Wieczorek
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 8.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

9.  Csx: a murine homeobox-containing gene specifically expressed in the developing heart.

Authors:  I Komuro; S Izumo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  The evolutionary relationship of avian and mammalian myosin heavy-chain genes.

Authors:  L A Moore; W E Tidyman; M J Arrizubieta; E Bandman
Journal:  J Mol Evol       Date:  1993-01       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.